Opaleye Management Inc. - Q3 2013 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q3 2013
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CODEXIS INC39Q3 202310.9%
CHIMERIX INC31Q3 202216.4%
XOMA CORP DEL27Q3 20233.6%
FIBROGEN INC26Q1 20216.8%
BIOLINERX LTD (Does not reflect a reverse stock split effectuated after June 30, 2019)26Q1 20202.4%
OCULAR THERAPEUTIX INC24Q3 202317.6%
AXOGEN INC20Q4 201918.7%
ETON PHARMACEUTICALS INC20Q3 20235.6%
AMARIN CORP PLC20Q4 20206.6%
IMPRIMIS PHARMACEUTICALS INC19Q1 20205.9%

View Opaleye Management Inc.'s complete holdings history.

Latest significant ownerships (13-D/G)
Opaleye Management Inc. Q3 2013 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
CHIMERIX INCSold outFebruary 13, 202300.0%
Larimar Therapeutics, Inc.January 23, 20231,560,0003.6%
TELA Bio, Inc.June 10, 20221,557,50010.7%
Gemini Therapeutics, Inc. /DESold outFebruary 01, 202200.0%
Adamas Pharmaceuticals IncSold outJanuary 26, 202200.0%
AVENUE THERAPEUTICS, INC.February 12, 2021911.0%
Cardiff Oncology, Inc.February 12, 2021911.0%
EDAP TMS SAFebruary 12, 2021911.0%
Fortress Biotech, Inc.February 12, 2021911.0%
Gemini Therapeutics, Inc. /DEFebruary 12, 2021911.0%

View Opaleye Management Inc.'s complete significant-ownership history.

Latest filings
TypeFiled
42024-05-17
13F-HR2024-05-15
42024-05-10
42024-04-25
42024-04-24
42024-04-19
SC 13G/A2024-04-09
SC 13G2024-04-08
42024-03-28
42024-03-22

View Opaleye Management Inc.'s complete filings history.

All filings

View complete filings history.

Compare quarters

Export Opaleye Management Inc.'s holdings

CSVXLS